Showing results (151-160 of 327) with videos related to

Sort By:
Pageof 33
CJEM|July 21, 2012
Compliance with the Canadian Association of Emergency Physicians' asthma clinical practice guidelines at a tertiary care emergency departmentLyne Filiatrault, David Harriman, Riyad B Abu-Laban, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 13, 2021
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in CanadaMohsen Sadatsafavi, J Mark FitzGerald, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology|December 15, 2019
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United StatesMohsen Yaghoubi, Amin Adibi, Zafar Zafari, et al.
Journal of the American College of Cardiology|June 20, 2006
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary diseaseG B John Mancini, Mahyar Etminan, Bin Zhang, et al.
BMC Pulmonary Medicine|May 21, 2009
Economic burden of asthma: a systematic reviewKatayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, et al.
Respiratory Medicine|September 12, 2020
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UKJ Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, et al.
Endoscopy International Open|January 8, 2024
Safety and efficacy of physician-administered balanced-sedation for the endoscopic mucosal resection of large non-pedunculated colorectal polypsSunil Gupta, Rajiv Kurup, Neal Shahidi, et al.
The Lancet. Respiratory Medicine|March 18, 2020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling studyAmin Adibi, Don D Sin, Abdollah Safari, et al.
BMC Infectious Diseases|November 17, 2016
Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort studyLisa A Ronald, J Mark FitzGerald, Andrea Benedetti, et al.
Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
Pageof 33